Dr. Liza Maniquis-Smigel is leading a transformative shift in regenerative medicine at the Hawai’i Center for Regenerative Medicine. With her extensive training in Physical Medicine and Rehabilitation, she is now integrating advanced techniques to enhance patient outcomes. Recently returning from a mission in Honduras, where she provided care to underserved communities, Dr. Maniquis-Smigel continues to advocate for innovative treatment options in her clinics located in Honolulu and Hilo.
Pioneering Non-Cellular Regenerative Therapies
Dr. Maniquis-Smigel has long been a proponent of prolotherapy, utilizing dextrose-based injections to stimulate healing in tissues. Since 2003, she has trained healthcare professionals through the Hackett-Hemwall Patterson Foundation, contributing to annual service trips that treat thousands of patients globally. Her approach emphasizes precision, stating, “It’s not just what you inject—it’s where and how.”
This precision aligns perfectly with the Regenerative Protein Array (RPA) developed by Genesis Regenerative. This advanced therapy offers a non-cellular option that leverages screened placental tissue, providing a diverse array of over 300 proteins, including cytokines, growth factors, and microRNAs. This stands in contrast to traditional platelet-rich plasma (PRP) therapies, which typically deliver around forty active components.
Addressing Aging Cellular Limitations
Over her two-decade career, Dr. Maniquis-Smigel encountered the limitations of conventional therapies, particularly in aging patients. Diminished cellular efficacy often resulted in inconsistent treatment outcomes. The introduction of RPA has proved revolutionary, as it eliminates the need for blood draws and the associated variability and immune risks. This FDA-registered product is thoroughly screened to ensure safety, addressing potential issues such as cancer or systemic diseases in donors.
The RPA therapy reprograms the body’s environment, promoting healing across various systems, including neurological, musculoskeletal, and organ tissues. Since integrating RPA into her practice, Dr. Maniquis-Smigel has reported significant improvements in patients suffering from neuro-cognitive, autoimmune, and musculoskeletal disorders.
Quick, Effective Treatment Sessions
The application of RPA is designed for efficiency. Each session lasts approximately 15 minutes, resulting in minimal downtime for patients. The Honolulu clinic, located conveniently near the airport, welcomes visitors seeking relief while enjoying the beauty of the islands.
Dr. Maniquis-Smigel understands the emotional toll of mobility loss, stemming from her background as a former dancer. With specialized training in sports and performing arts medicine, she empathizes with those who face restrictions in their physical activities, whether in surfing, yoga, or other pursuits. RPA holds promise for both active individuals and the elderly, potentially allowing for recovery without the need for surgical interventions.
Empowering Patients with New Possibilities
Dr. Maniquis-Smigel likens RPA to restoring the body’s inherent capabilities. She describes it as akin to “handing the body its pre-puberty superpowers.” Her passion for enhancing patient outcomes drives her to collaborate with fellow regenerative medicine practitioners, ensuring that challenging cases receive the best care possible.
A Holistic Approach to Healing
At the Hawai’i Center for Regenerative Medicine, the focus is on holistic and patient-centered care. The clinic offers a variety of advanced treatments, including prolotherapy, IV nutrition, aesthetics, and, of course, the innovative RPA. The foundation of this practice is to optimize patients’ vitality and overall quality of life, ensuring each individual receives tailored care that addresses their unique needs.
Commitment to Ethical Practices
Genesis Regenerative is dedicated to establishing high standards in non-cellular regenerative products. Their commitment to ethical practices, rigorous product purity, and comprehensive educational support for both patients and practitioners reinforces their leadership in the industry. By prioritizing these values, they aim to set a new benchmark in regenerative medicine.
Future Directions in Regenerative Medicine
The adoption of RPA marks a significant advancement in the field, addressing the challenges posed by aging and tissue degeneration. As Dr. Maniquis-Smigel continues to refine her techniques and expand her offerings, the potential for regenerative medicine is vast. This innovative approach not only enhances healing but also redefines the patient experience, fostering hope and possibility.
In conclusion, the integration of Genesis Regenerative’s RPA at the Hawai’i Center for Regenerative Medicine signifies a new era in regenerative therapies. By prioritizing patient-centric care and leveraging cutting-edge technology, Dr. Maniquis-Smigel is not only transforming lives but also leading the way in the future of regenerative medicine.
- RPA offers over 300 proteins, surpassing traditional PRP.
- Quick treatment sessions with zero downtime enhance patient convenience.
- The therapy addresses a variety of health concerns, from autoimmune issues to musculoskeletal injuries.
- Ethical practices and rigorous testing underpin the safety and efficacy of RPA treatments.
- Dr. Maniquis-Smigel’s holistic approach aims to restore vitality and improve quality of life.
Read more → www.dispatch.com